(Q31082790)

12 November 2017

The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis (English)

1 reference

cost-effectiveness analysis

12 November 2017

anti-retroviral agent

0 references

South Africa

0 references

data analysis

0 references

1 reference

Di McIntyre

2

0 references

Andrew Boulle

object named as

Andrew M Boulle

series ordinal

3

0 references

author name string

Susan M Cleary

series ordinal

1

1 reference

12 November 2017

6 December 2006

1 reference

Cost Effectiveness and Resource Allocation

12 November 2017

1 reference

12 November 2017

4

1 reference

12 November 2017

20

1 reference

https://scigraph.springernature.com/pub.10.1186/1478-7547-4-20

12 November 2017

0 references

cites work

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Scaling up access to antiretroviral treatment in southern Africa: who will do the job?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa

21 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

21 June 2018

12 December 2020

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

The estimation of a preference-based measure of health from the SF-36.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Allowing for differential timing in cost analyses: discounting and annualization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

An introduction to Markov modelling for economic evaluation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Scaling up antiretroviral treatment in resource-poor settings

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Model for simulation of HIV/AIDS and cost-effectiveness of preventing non-tuberculous mycobacterial (MAC)-disease

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Estimating resource needs for HIV/AIDS health care services in low-income and middle-income countries.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

The cost effectiveness of combination antiretroviral therapy for HIV disease.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

CD4 and total lymphocyte counts as predictors of HIV disease progression

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Markov models in medical decision making: a practical guide.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770938

Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?

25 November 2018

1 reference

12 December 2020

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

12 December 2020

Assessing the cost-effectiveness of HAART for adults with HIV in England

1 reference

12 December 2020

Incorporation of uncertainty in health economic modelling studies

1 reference

12 December 2020

Identifiers

DOI

10.1186/1478-7547-4-20

1 reference

PMCID

1770938

Dimensions Publication ID

12 November 2017

0 references

1 reference

12 November 2017

1 reference

PMCID

1770938